<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-283
Date of Submission: 2024-08-30

This report was submitted by a Other Healthcare Professional from Long, Larson and Hamilton Medical Center concerning patient ANON-PX-5509. The subject is an adult other with a significant medical history including osteoarthritis, type 2 diabetes, atrial fibrillation, asthma. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Sertraline (SSRI) administered via the Subcutaneous route at a dosage of 13mg, initiated on 2024-08-08 for Major depressive disorder and discontinued on 2024-08-27.

On approximately 2024-08-24, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Anaphylaxis, Dizziness, Diarrhea. The Anaphylaxis was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Not Recovered'. The Dizziness was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. The Diarrhea was classified as Severe in severity. This necessitated clinical intervention. The documented action was: Prescribed door and advised partner. The current patient status regarding this symptom is 'Not Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 2 was calculated, The assessment concluded the relationship was 'Possible'. Dechallenge/Rechallenge status was noted as: 'Rechallenge not performed'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Executive bad position product personal. Way message manage but finish care.</data>
report_id: ADR-2024-283
report_date: '2024-08-30'
patient_details:
  patient_id: ANON-PX-5509
  gender: Other
  relevant_history:
  - osteoarthritis
  - type 2 diabetes
  - atrial fibrillation
  - asthma
suspected_drugs:
- drug_name: Sertraline
  dosage: 13mg
  route_of_administration: Subcutaneous
  start_date: '2024-08-08'
  indication_for_use: Major depressive disorder
  drug_class: SSRI
  end_date: '2024-08-27'
adverse_reactions:
- symptom_name: Anaphylaxis
  onset_date: '2024-08-24'
  severity: Moderate
  outcome: Not Recovered
  intervention_required: false
- symptom_name: Dizziness
  onset_date: '2024-08-24'
  severity: Mild
  outcome: Recovered
  intervention_required: false
- symptom_name: Diarrhea
  onset_date: '2024-08-24'
  severity: Severe
  outcome: Not Recovered
  intervention_required: true
  intervention_details: Prescribed door and advised partner.
causality_assessment:
  assessment_conclusion: Possible
  dechallenge_rechallenge: Rechallenge not performed
  naranjo_score: 2
reporting_facility: Long, Larson and Hamilton Medical Center
reporter_type: Other Healthcare Professional
notes: Executive bad position product personal. Way message manage but finish care.
